Prothena
PRTA
$20.56
Share price
0.00%
Change (1 day)
-62.09%
Change (1 year)
Categories
Earnings for Prothena (PRTA)
Earnings in 2023 (TTM): -$0.2 B
According to Prothena's latest financial reports the company's current earnings (TTM) are -$0.2 B. In 2022 the company made an earning of -$0.14 B a decrease over its 2021 earnings that were of $71.97 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Prothena from 2012 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.2 B | 45.21% |
| 2022 | -$0.14 B | -282.78% |
| 2021 | $71.97 M | -163.84% |
| 2020 | -$0.12 B | 33.94% |
| 2019 | -$84.17 M | -44.78% |
| 2018 | -$0.16 B | -0.97% |
| 2017 | -$0.16 B | -3.33% |
| 2016 | -$0.16 B | 99.17% |
| 2015 | -$79.94 M | 1102.24% |
| 2014 | -$6.65 M | -83.55% |
| 2013 | -$40.43 M | -2.37% |
| 2012 | -$41.41 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Amarin Corporation
AMRN | -$53.67 M | -71.91% | 🇮🇪 Ireland |
 Alnylam Pharmaceuticals
ALNY | -$0.32 B | 63.47% | 🇺🇸 USA |
 Alkermes ALKS | $0.44 B | -332.71% | 🇮🇪 Ireland |